Showing promise in the field of weight management management, retatrutide presents a different approach. Different from many available medications, retatrutide works as a double agonist, at once targeting both GLP-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic polypeptide (GIP) receptors. The simultaneous stimulation fosters multiple a